Products

NeuraMetrix
NeuraMetrix
Lab & Diagnostics
NeuraMetrix offers a passive digital brain health biomarker, measuring typing inconsistency to detect and monitor neurological diseases and psychiatric disorders.

See all 1 product →

About NeuraMetrix

NeuraMetrix is a Software as a Medical Device (SaMD) company focused on brain health. It utilizes a patented digital biomarker, NeuraMetrix Typing Cadence (TC), to detect and monitor neurological diseases and psychiatric disorders by continuously measuring typing inconsistency.

The company’s goal is to significantly improve care for patients with various neurological and psychiatric conditions. It aims to provide researchers, physicians, and patients with passive, continuous, exceptionally precise, and accurate measurements of brain health.

Focus Areas

Neurological disorders Psychiatric disorders Digital biomarkers Parkinson's Disease Alzheimer's Disease Huntington's Disease Depression Brain health monitoring Cognitive assessment

Business Intelligence

TechnologyProprietary algorithms analyzing sub-second keystroke timing, Software as a Medical Device (SaMD), Passive digital biomarker (Typing Cadence - TC)

What Physicians Need to Know

Specialization
NeuraMetrix specializes in detecting and monitoring neurological diseases and psychiatric disorders.
Key Differentiator
Their core technology is the NeuraMetrix Typing Cadence (TC) passive digital brain health biomarker, which measures typing inconsistency.
Technology Stack
The technology is based on a patented digital biomarker (US Patents 10,694,947 and 10,694,987, Australian Patent 2016268858, and Japanese Patent 6959911) that measures typing inconsistency to detect and monitor conditions.
FDA Designation
NeuraMetrix has been designated a “Breakthrough Device” by the US FDA for Parkinson’s Disease.
Product Status
It is not FDA-cleared or CE-marked but can be sold globally under Institutional Review Board (IRB) approval for research.
Target Diseases
The technology is applicable to Alzheimer's, Parkinson's, Huntington's, and Depression, as well as other neurological and psychiatric disorders.
Monitoring Approach
The solution provides passive, continuous, exceptionally precise, and accurate measurements of brain health.
Physician Tip

For physicians, NeuraMetrix offers a novel, unique, and highly accurate digital biomarker for the continuous and passive detection and monitoring of various neurological and psychiatric disorders. The technology's ability to measure typing inconsistency provides an objective and precise metric for brain health, potentially revolutionizing how these conditions are assessed and managed. The FDA Breakthrough Device designation for Parkinson's Disease highlights its potential clinical significance. While not yet FDA-cleared for general clinical use, its availability for research under IRB approval allows for its integration into clinical studies and research settings to gather further evidence and improve patient care.

Products by NeuraMetrix

1 product in the directory

NeuraMetrix
NeuraMetrix
Lab & Diagnostics
NeuraMetrix offers a passive digital brain health biomarker, measuring typing inconsistency to detect and monitor neurological diseases and psychiatric disorders.

Videos

News, demos, and interviews about NeuraMetrix.

Loading videos...

Videos load interactively. If none appear, search YouTube for NeuraMetrix →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

NeuraMetrix Typing Cadence (TC) is a patented passive digital brain health biomarker that measures typing inconsistency to detect and monitor neurological diseases and psychiatric disorders.
NeuraMetrix Typing Cadence (TC) is intended for detecting and monitoring neurological diseases and psychiatric disorders, including Alzheimer's, Parkinson's, Huntington's, and Depression.
NeuraMetrix Typing Cadence (TC) provides physicians with passive, continuous, precise, and accurate measurements of brain health for patients with various neurological and psychiatric disorders.
NeuraMetrix Typing Cadence (TC) has been designated a “Breakthrough Device” by the US FDA for Parkinson’s Disease and can be sold globally under Institutional Review Board (IRB) approval for research.
NeuraMetrix aims to improve care for patients by providing researchers, physicians, and patients with measurements of brain health.

Related Companies

Vitestro is a company dedicated to redefining diagnostic blood collection through automation. Their flagship product, Aletta®, is the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). Aletta automates the entire diagnostic blood collection process, aiming to set a new standard for efficiency and consistency in phlebotomy. The company addresses global challenges in manual phlebotomy, such as […]

LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]

The company’s technology analyzes acoustic and linguistic patterns from brief speech samples to detect behavioral and cognitive changes, often before traditional clinical standards or noticeable symptoms appear. This allows for proactive screening and assessments for conditions such as anxiety, depression, and neurodegenerative disorders like Alzheimer’s, Huntington’s, and Parkinson’s disease. Canary Speech’s mission is to improve […]

Tidepool is a 501(c)(3) nonprofit organization focused on making diabetes data more accessible, actionable, and meaningful for individuals with diabetes, their care teams, and researchers. Founded by individuals with diabetes, caregivers, and healthcare providers, Tidepool aims to help people with insulin-requiring diabetes achieve better outcomes through intuitive software products. The Tidepool Data Platform integrates data […]

VitalTech offers a comprehensive enterprise solution for virtual care coordination, designed to integrate seamlessly into existing healthcare workflows. Their platform, VitalCare, provides real-time actionable insights from patient data, aiming to improve patient outcomes, care, and safety. It enables patients to upload vital measurements, track nutrition and medication, message caregivers, and answer surveys. For clinicians, VitalCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.